The protein levels of cleaved caspase 3 and cleaved PARP were elevated in PTGES‐knockdown osteosarcoma cells, and cells treated with lobaplatin demonstrated more significant differences in these proteins than those without lobaplatin treatment (Figure 6A). This evidence concerns the gene CASP3 and osteosarcoma.